Table 2

Baseline detection rates based on 928 colonoscopies by trained endoscopists and 6069 colonoscopies by untrained endoscopists*

Endoscopists in intervention arm (n=17)Endoscopists in control arm (n=100)P value†
≥1 Proximal SP (=PSPDR), % (95% CI)9.3% (7.4% to 11%)9.3% (8.6% to 10%)0.48
 ≥1 SP23% (20% to 26%)24% (23% to 25%)0.87
 ≥1 HP20% (17% to 22%)20% (19% to 21%)0.61
 ≥1 SSL5.9% (4.4% to 7.4%)5.4% (4.9% to 6.0%)0.72
 ≥1 TSA1.1% (0.4% to 1.7%)1.4% (1.1% to 1.8%)0.49
≥1 Adenoma (=ADR), % (95% CI)66% (63% to 70%)66% (65% to 68%)0.99
 ≥1 Advanced adenoma41% (38% to 44%)45% (44% to 47%)0.13
  • Percentages ≥10% are rounded to the nearest integer.

  • *Based on colonoscopies in 2014 prior to the first training session (trained endoscopists), or all colonoscopies in 2014 (untrained endoscopists).

  • †P values are based on mixed-effects logistic regression analyses, with fixed effects for training and adjusted with random intercepts for type of centre and endoscopist.

  • ADR, adenoma detection rate; HP, hyperplastic polyp; PSPDR, proximal serrated polyp detection rate; SP, serrated polyp; SSL, sessile serrated lesion; TSA, traditional serrated adenoma.